Agenda
Schedule | ||
---|---|---|
8:30am- 8:40am | Opening Remarks |
Dr. Susan Furth, MD, PhD |
8:40am- 9:10am | Morning Keynote: “History of Vaccine Development in Philadelphia” |
Stanley A. Plotkin, MD Professor Emeritus, Department of Pediatrics, Penn Perelman School of Medicine |
9:10am-10:10am | Session 1: Vaccines in Model Systems | |
9:10am-9:30am | “Immune-focused SARS-CoV-2 nanoparticles drive rapid and potent immunogenicity capable of single-dose protection” | Daniel Kulp, PhD- Associate Professor, Vaccine & Immunotherapy Center, The Wistar Institute |
9:30am-9:50am | “Sequential immunization strategies to elicit broadly neutralizing antibodies against HIV” | Amelia Escolano, PhD- Assistant Professor, Vaccine & Immunotherapy Center, The Wistar Institute |
9:50am-10:10am | “Nucleoside-modified mRNA vaccine to prevent genital herpes” | Harvey Friedman, MD- Professor of Medicine, Penn Perelman School of Medicine |
10:10am-10:30am |
Break | |
10:30am-11:50am |
Session 2: Determinants of Vaccine-induced Immunity | |
10:30am-10:50am | “Development of a multivalent mRNA influenza vaccine to replace original antigenic sin with initial blessings of induced immunity” | Scott Hensley, PhD- Professor of Microbiology, Penn Perelman School of Medicine |
10:50am-11:10am |
“Immune Health and immunity to SARS-CoV-2 vaccines” |
John Wherry, PhD- Richard and Barbara Schiffrin President’s Distinguished Professor; Chair, Department of Systems Pharmacology and Translational Therapeutics, Penn Perelman School of Medicine |
11:10am-11:30am | “Vaccine Readiness after Immune Reconstitution” | Laura Vella, MD, PhD- Assistant Professor of Pediatrics, Children’s Hospital of Philadelphia |
11:30am-11:50am | “Immune responses to SARS-CoV-2 mRNA vaccines in human lymph nodes” | Michela Locci, PhD- Assistant Professor of Microbiology, Penn Perelman School of Medicine |
11:50am-12:30pm |
Lunch | |
12:30pm-1:00pm |
Afternoon Keynote: “Nucleoside Modified mRNA-LNP Therapeutics” |
Drew Weissman, MD, PhD- Roberts Family Professor in Vaccine Research; Director, Penn Institute for RNA Innovation, Penn Perelman School of Medicine |
1:00pm-2:00pm |
Session 3: Vaccine Design, Adjuvants, and Delivery Systems | |
1:00pm-1:20pm | "Invivo Genetic Delivery for tailoring immunization and immuno-biologics" | David B. Weiner, PhD- Director, Vaccine & Immunotherapy Center; W.W. Smith Charitable Trust Professor in Cancer Research, Immunology, Microenvironment & Metastasis Program, The Wistar Institute |
1:20pm-1:40pm | “An MHC-independent synthetic vaccine-Boosting CAR T cell therapy and endogenous anti-tumor immunity in tandem” | Leyuan Ma, PhD- Assistant Professor of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia |
1:40pm-2:00pm | “Lipid nanoparticles are broadly applicable T follicular helper cell and humoral immune response adjuvants” | Norbert Pardi, PhD- Assistant Professor of Microbiology, Penn Perelman School of Medicine |
2:00pm-3:00pm |
Session 4: Clinical Trials in Vaccination | |
2:00pm-2:20pm |
“COVID-19 Vaccines for Children” |
Jeffrey Gerber, MD, PhD, MSCE- Werner and Gertrude Henle Endowed Chair, Department of Pediatrics, Children’s Hospital of Philadelphia |
2:20pm-2:40pm | "Covid vaccine in adults, new strains and correlates of protection" | Pablo Tebas, MD- Professor of Medicine, Penn Perelman School of Medicine |
2:40pm-3:00pm |
“Targeting Tumor Neoantigens” |
Beatriz Carreno, PhD- Research Associate Professor in Pathology and Laboratory Medicine, Penn Perelman School of Medicine |
3:00pm-3:20pm |
Break | |
3:20pm-4:10pm |
Session 5: Vaccine Policy | |
3:20pm-3:45pm | “Minimizing the viral spread of bogus tales of vaccination side effects” | Kathleen Hall Jamieson, PhD- Elizabeth Ware Packard Professor of Communication; Director, Annenberg Public Policy Center |
3:45pm-4:10pm | "Approving COVID-19 Vaccines for Children: When Do We Know Enough?" | Paul Offit, PhD- Maurice R. Hilleman Chair of Vaccinology |
4:10pm-4:40pm |
Roundtable: What Makes a Leading Vaccine Center Moderators: Laura Vella, MD, PhD & Norbert Pardi, PhD |
Jeffrey Gerber, MD, PhD |
4:40pm-5:00pm |
Closing Remarks |
Dr. Jonathan Epstein, MD |
5:00pm-6:00pm |
Reception |